Catégorie : Uncategorized

novembre 5, 2019 0

Imbrium Therapeutics annonce le premier patient traité dans le cadre d'une étude de phase 2 sur une molécule potentielle de première classe pour l'insomnie associée à la cessation de l'alcool

Par admin

Translating… STAMFORD, Conn.–(BUSINESS WIRE)–Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., today announced the first dose administered in the Phase 2 clinical study (OAG2002) of its novel, potentially first-in-class small molecule IMB-115 for the treatment of insomnia associated with alcohol cessation (IAAC). The randomized, double-blind, placebo-controlled, multi-center, parallel-group study…

novembre 4, 2019 0

Imbrium Therapeutics annonce le premier patient traité dans le cadre d'une étude de phase 2 sur une molécule potentielle de première classe pour l'insomnie associée à la cessation de l'alcool

Par admin

Translating… STAMFORD, Conn.–(BUSINESS WIRE)–Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., today announced the first dose administered in the Phase 2 clinical study (OAG2002) of its novel, potentially first-in-class small molecule IMB-115 for the treatment of insomnia associated with alcohol cessation (IAAC). The randomized, double-blind, placebo-controlled, multi-center, parallel-group study…

octobre 5, 2019 0

ResMed célébrera son 30e anniversaire et ses 20 ans de cotation à la Bourse de New York en sonnant à l'ouverture Bell® le 30 septembre 2019

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD, ASX: RMD) today announced that CEO Mick Farrell will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Monday, September 30, 2019 at 9:30 a.m. ET. Farrell will be joined on the bell podium with other members of the ResMed management team to celebrate 20 years…

octobre 4, 2019 0

ResMed célèbre son 30e anniversaire et ses 20 ans de cotation à la Bourse de New York en sonnant à l'ouverture Bell® le 30 septembre 2019

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD, ASX: RMD) today announced that CEO Mick Farrell will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Monday, September 30, 2019 at 9:30 a.m. ET. Farrell will be joined on the bell podium with other members of the ResMed management team to celebrate 20 years…

octobre 3, 2019 0

ResMed célèbre son 30e anniversaire et ses 20 ans de cotation à la Bourse de New York en sonnant à l'ouverture Bell® le 30 septembre 2019

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD, ASX: RMD) today announced that CEO Mick Farrell will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Monday, September 30, 2019 at 9:30 a.m. ET. Farrell will be joined on the bell podium with other members of the ResMed management team to celebrate 20 years…

septembre 29, 2019 0

ResMed célébrera son 30e anniversaire et ses 20 ans de cotation à la Bourse de New York en sonnant à l'ouverture Bell® le 30 septembre 2019

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD, ASX: RMD) today announced that CEO Mick Farrell will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Monday, September 30, 2019 at 9:30 a.m. ET. Farrell will be joined on the bell podium with other members of the ResMed management team to celebrate 20 years…

septembre 28, 2019 0

ResMed célébrera son 30e anniversaire et ses 20 ans de cotation à la Bourse de New York en sonnant à l'ouverture Bell® le 30 septembre 2019

Par admin

Translating… We Apologize for the Inconvenience. Our Team is Working to Resolve the Issue. If You Have Questions or Need to Submit Your News Release, Please Contact Your Local Business Wire Bureau: US: 1.888.381.WIRE(9473) Australia: 61 2.9004.7015 Canada: 1.416.593.0208 France: 33 1.56.88.29.40 Germany: 49 69.915066.0 Hong Kong: 852.3602.3091 Japan: 81 3.3239.0755 UK: 44 20.7626.1982 Huile…

septembre 11, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…

septembre 10, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…

septembre 8, 2019 0

ResMed annonce sa participation à la 17ème conférence annuelle de Morgan Stanley Global Healthca

Par admin

Translating… SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD) today announced that David Pendarvis, chief administrative officer and global general counsel, will participate in a fireside chat at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, beginning at approximately 2:50 p.m. (Eastern Time) at the Grand Hyatt New York in New…